Mr Muneer completed an MD at the Wolfson Institute of Biomedical Research, UCL investigating the role of ischaemia and smooth muscle dysfunction. This has led to a change in the management of ischaemic priapism with UCLH leading on the use of acute penile prosthesis insertion for refractory cases. Following on from this his focus has been on developing a penile cancer tissue biobank at UCL which has led to a collaboration with the UCL Cancer Institute to perform the first whole exome sequencing for penile cancer. Currently he is the clinical lead and PI for the MRI-PET trial for staging inguinal nodes in penile cancer which has now recruited the largest number of patients for a penile cancer trial. There is now ongoing work to develop in vitro models to investigate novel targeted therapies which will form the basis for a translational arm to the penile cancer research. The penile cancer team are also investigating the life cycle of low risk HPV and continue to investigate novel imaging techniques for the management of clinically impalpable disease.